Hematology Oncology Grand RoundsCourse Directors: Drs. Edward A. Faber, Jr. and Pier Paolo ScaglioniConference Coordinator: Gayle Pollack

Segment 1: Early Relapse with No ComorbiditiesDespite advances in the initial treatment strategies of multiple myeloma, many patients will experience an early relapse. The further management of such patients can be challenging given the various options and complex patient- and disease-related factors.Conversations and Cases in Multiple Myeloma is a roundtable discussion activity designed to inform and guide on integrating recent progress in the management of early relapse. The expert faculty wil...

Segment 2: Early Relapse with ComorbiditiesDespite advances in the initial treatment strategies of multiple myeloma, many patients will experience an early relapse. The further management of such patients can be challenging given the various options and complex patient- and disease-related factors.Conversations and Cases in Multiple Myeloma is a roundtable discussion activity designed to inform and guide on integrating recent progress in the management of early relapse. The expert faculty will d...

Segment 3: Early Relapse with High-Risk CytogeneticsDespite advances in the initial treatment strategies of multiple myeloma, many patients will experience an early relapse. The further management of such patients can be challenging given the various options and complex patient- and disease-related factors.Conversations and Cases in Multiple Myeloma is a roundtable discussion activity designed to inform and guide on integrating recent progress in the management of early relapse. The expert facul...

Conversations and Updates in Myelodysplastic Syndromes: Practice-Changing Expert Insights in Lower- and Higher-Risk MDSSegment 1: Updates in the Diagnosis and Risk Stratification of MDSConversations and Updates in Myelodysplastic Syndromes (MDS) is a roundtable discussion activity designed to inform and guide on the latest practice-changing insights to improve outcomes in both lower- and higher-risk MDS. The expert faculty presenters will discuss recent evidence and provide guidance on classifyi...

Conversations and Updates in Myelodysplastic Syndromes: Practice-Changing Expert Insights in Lower- and Higher-Risk MDSSegment 2: Updates in the Therapeutic Management of Lower-Risk MDSConversations and Updates in Myelodysplastic Syndromes (MDS) is a roundtable discussion activity designed to inform and guide on the latest practice-changing insights to improve outcomes in both lower- and higher-risk MDS. The expert faculty presenters will discuss recent evidence and provide guidance on classifyi...

Conversations and Updates in Myelodysplastic Syndromes: Practice-Changing Expert Insights in Lower- and Higher-Risk MDSSegment 3: Updates in the Therapeutic Management of Higher Risk-MDSConversations and Updates in Myelodysplastic Syndromes (MDS) is a roundtable discussion activity designed to inform and guide on the latest practice-changing insights to improve outcomes in both lower- and higher-risk MDS. The expert faculty presenters will discuss recent evidence and provide guidance on classify...

Sarcoma Melanoma Multidisciplinary Tumor BoardCourse Director:  Amanda Jackson, MDConference Coordinator:  Rayvetta Bryant

Despite continual progress in the treatment and management of acute myeloid leukemia (AML), relapse rates following allogeneic stem cell transplantation remain unacceptably high and a major cause of death. There have been various attempts to improve outcomes in this setting of AML which need to be integrated on a case-by-case basis.This archived series, led by expert faculty, will provide guidance and practical strategies to safely implement recent progress in addressing post-transplantation rel...

This online course is a recording of the live Internal Medicine Medical Grand Rounds presentation on January 12, 2022.Learners should not claim credit for both the live session and this online course; review your transcript to determine if you received credit for the live session before taking this course. Speaker of this presentation cannot claim credit.Course Structure:1.  Review CME Front Matter, and review speaker/planning member's disclosure information located i...